Madrigal Pharmaceuticals, Inc. (MDGL): Total Liabilities
$656.90M
As of 2025-12-31
$720.92M
As of 2026-06-30
+58.4%
3-year compound annual growth
+69.4%
5-year compound annual growth
+29.6%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $656.90M | +128.2% | 2026-02-19, Balance as of period end |
| 2024-12-31 | $287.86M | +22.4% | 2026-02-19, Balance as of period end |
| 2023-12-31 | $235.21M | +42.4% | 2025-02-26, Balance as of period end |
| 2022-12-31 | $165.18M | +113.9% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $77.22M | +64.2% | 2023-03-03, Balance as of period end |
| 2020-12-31 | $47.02M | +84.5% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $25.49M | +201.9% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $8.44M | -16.0% | 2020-02-26, Balance as of period end |
| 2017-12-31 | $10.05M | +109.5% | 2019-02-27, Balance as of period end |
| 2016-12-31 | $4.80M | -90.3% | 2018-03-13, Balance as of period end |
| 2015-12-31 | $49.28M | +38.7% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $35.54M | -22.9% | 2016-03-15, Balance as of period end |
| 2013-12-31 | $46.11M | +65.0% | 2015-03-12, Balance as of period end |
| 2012-12-31 | $27.95M | +1.5% | 2014-03-11, Balance as of period end |
| 2011-12-31 | $27.55M | -9.9% | 2013-03-14, Balance as of period end |
| 2010-12-31 | $30.59M | n/a | 2012-02-22, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $656.90M | +128.2% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $3.03B | +25.6% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $899.65M | +5.1% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $401.41M | +18.0% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $336.81M | -26.0% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $1.61B | +2.5% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.36B | -5.5% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $188.85M | +17.3% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $796.00M | -12.2% |
Compare MDGL, IONS, ANIP, HRMY side by side · Screen every company in Pharmaceutical Preparations ↗